Shares in Amerisourcebergen (NYQ:ABC) are currently trading at 98.97, but a key question for investors is how much the current economic uncertainty will affect the price. One way of making that assessment is to look at the profile of t...
ABC — AmerisourceBergen Share Price
- $32.31bn
- $35.77bn
- $213.99bn
- 81
- 62
- 97
- 92
Momentum
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 13.6 | ||
PEG Ratio (f) | 1.23 | ||
EPS Growth (f) | 12.46% | ||
Dividend Yield (f) | 1.23% |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 58.72 | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | 11.34 | ||
Price to Sales | 0.14 | ||
EV to EBITDA | 10.91 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 17.97% | ||
Return on Equity | 1286.11% | ||
Operating Margin | 1.14% |
Financial Summary
Year End 30th Sep | Unit | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E | 2023E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 153,143.83 | 167,939.64 | 179,589.12 | 189,893.93 | 213,988.84 | 237,322.54 | 249,018.2 | 7.82% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | -30.04 | +32.85 | +16.14 | -10.5 | +37.49 | +29.54 | +5.43 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Health Trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Latest News & Insights for ABC
If, as an investor, you’re only looking at sales and earnings growth, there's a chance that a vital question is not being asked: how is that growth being funded? Top analysts and investors such as Warren Buffett and Michael Mauboussin...
Quality and momentum are highly prized among investors looking for reliable investment ideas. That's because good quality stocks tend to be resilient, cash-generating businesses that can compound investment returns over time. And those...
Profile Summary
AmerisourceBergen Corporation is a global pharmaceutical sourcing and distribution services company. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes an offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services. This segment consists of Alliance Healthcare, World Courier, Innomar, Profarma, and Profarma Specialty.
Directors
- Steven Collis CHM (60)
- James Cleary CFO (58)
- Silvana Battaglia CHO (54)
- Gina Clark EVP (64)
- Elizabeth Campbell EVP (47)
- John Chou EVP (65)
- Leslie Donato EVP (52)
- Robert Mauch EVP (54)
- Jane Henney LED (74)
- Ornella Barra DRC (69)
- D. Mark Durcan IND (60)
- Richard Gochnauer IND (72)
- Lon Greenberg IND (71)
- Kathleen Hyle IND (63)
- Michael Long IND (63)
- Henry McGee IND (68)
- Dennis Nally IND (69)
- Last Annual
- September 30th, 2021
- Last Interim
- March 31st, 2022
- Incorporated
- March 16th, 2001
- Public Since
- December 16th, 1993
- No. of Shareholders
- 2,315
- No. of Employees
- 38,000
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
New York Stock Exchange
- Shares in Issue
- 209,464,050

- Address
- 1 WEST FIRST AVENUE, CONSHOHOCKEN, 19428
- Web
- https://www.amerisourcebergen.com/
- Phone
- +1 6107277000
- Auditors
- Ernst & Young LLP
Upcoming Events for ABC
Amerisourcebergen Corp Investor Day
Q3 2022 Amerisourcebergen Corp Earnings Release
Q4 2022 Amerisourcebergen Corp Earnings Release
Similar to ABC
Abbott Laboratories
New York Stock Exchange
Agilent Technologies
New York Stock Exchange
Agiliti
New York Stock Exchange
Alcon AG
New York Stock Exchange
Artivion
New York Stock Exchange
FAQ
As of Today at 01:01 UTC, shares in AmerisourceBergen are trading at $154.27. This share price information is delayed by 15 minutes.
Shares in AmerisourceBergen last closed at $154.27 and the price had moved by +34.16% over the past 365 days. In terms of relative price strength the AmerisourceBergen share price has outperformed the S&P500 Index by +41.49% over the past year.
The overall consensus recommendation for AmerisourceBergen is Buy. You can view the full broker recommendation list by unlocking its StockReport.
The AmerisourceBergen dividend yield is 1.17% based on the trailing twelve month period.
Last year, AmerisourceBergen paid a total dividend of $1.80, and it currently has a trailing dividend yield of 1.17%. We do not have any data on when AmerisourceBergen is to next pay dividends.
We do not have data on when AmerisourceBergen is to next pay dividends. The historic dividend yield on AmerisourceBergen shares is currently 1.17%.
To buy shares in AmerisourceBergen you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $154.27, shares in AmerisourceBergen had a market capitalisation of $32.31bn.
Here are the trading details for AmerisourceBergen:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: ABC
Based on an overall assessment of its quality, value and momentum AmerisourceBergen is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in AmerisourceBergen is $171.18. That is 10.96% above the last closing price of $154.27.
Analysts covering AmerisourceBergen currently have a consensus Earnings Per Share (EPS) forecast of $10.96 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like AmerisourceBergen. Over the past six months, its share price has outperformed the S&P500 Index by +50.13%.
As of the last closing price of $154.27, shares in AmerisourceBergen were trading +14.29% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The AmerisourceBergen PE ratio based on its reported earnings over the past 12 months is 13.6. The shares last closed at $154.27.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
AmerisourceBergen's management team is headed by:
- Steven Collis - CHM
- James Cleary - CFO
- Silvana Battaglia - CHO
- Gina Clark - EVP
- Elizabeth Campbell - EVP
- John Chou - EVP
- Leslie Donato - EVP
- Robert Mauch - EVP
- Jane Henney - LED
- Ornella Barra - DRC
- D. Mark Durcan - IND
- Richard Gochnauer - IND
- Lon Greenberg - IND
- Kathleen Hyle - IND
- Michael Long - IND
- Henry McGee - IND
- Dennis Nally - IND